ac0010ma
Small moleculeexperimental
Clinical trial activity
7 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02274337)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ac0010
- ac0010ma
- ac0010ma
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03300115 | Phase 2 | May 18, 2017 | Acea Bio, Shantou University |
| NCT03060850 | Phase 1 | Feb 28, 2017 | Acea Bio |
| NCT03001609 | Phase 1 | Nov 1, 2016 | Acea Bio, Nanjing Medical University |
| NCT03053219 | Phase 1 | Nov 1, 2016 | Acea Bio |
| NCT02448251 | Phase 1/Phase 2 (Phase 2) | May 1, 2015 | Acea Bio, City of Hope National Medical Center, Emory University, University of Colorado, University of Texas at Houston, Wayne State University |
| NCT02330367 | Phase 1 | Jan 1, 2015 | Acea Bio, Shantou University |
| NCT02274337 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2014 | Acea Bio, Sun Yat-Sen University |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Acea Bio | For profit | 7 | 6 | 2 | 2014 |
| Shantou University | Academic/Hospital | 2 | 0 | 2 | 2015 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Nanjing Medical University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of Colorado | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Wayne State University | Academic/Hospital | 1 | 0 | 1 | 2015 |
9 organizations
Page 1 / 1